If You Invested in Dicerna (DRNA)
See the DRNA overviewWhat $1,000 or $10,000 in DRNA Was Worth at Its Last Close
Real historical value by amount invested and how long before the last close| If you invested | 1 year before | 5 years before | 10 years before | Since Nov 3, 2015 |
|---|---|---|---|---|
| $1,000 | $1,715 +72% | $11,241 +1,024% | — | $3,284 +228% |
| $10,000 | $17,154 +72% | $112,412 +1,024% | — | $32,835 +228% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2021-12-27. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for DRNA$1,000 Investment Over Time
DRNA vs S&P 500Year-by-Year Returns
DRNA annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2015Nov 3, 2015 to Dec 31, 2015 | $11.64 | $11.87 | +2.0% | +2.0% |
| 2016 | $11.87 | $2.88 | -75.7% | -75.3% |
| 2017 | $2.88 | $9.03 | +213.5% | -22.4% |
| 2018 | $9.03 | $10.69 | +18.4% | -8.2% |
| 2019 | $10.69 | $22.03 | +106.1% | +89.3% |
| 2020 | $22.03 | $22.03 | +0.0% | +89.3% |
| 2021Dec 31, 2020 to Dec 27, 2021 | $22.03 | $38.22 | +73.5% | +228.4% |
About Dicerna
NASDAQ
Frequently Asked Questions
Dicerna investment returns
How much was $1,000 invested in Dicerna worth at its last close?
If you invested $1,000 in Dicerna (DRNA) 5 years before its last close, on 2016-12-27, your investment was worth $11,241 on 2021-12-27, a +1,024.1% price return without dividends, growing at a compounded rate of 62.3% per year (CAGR).
Has Dicerna outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare DRNA performance over available time periods.
What is Dicerna's average annual return?
The compound annual growth rate (CAGR) of DRNA’s share price over the 5 years to Dec 27, 2021 is 62.3%, without dividends. Individual years vary a great deal, and DRNA’s best recent full year was 2017 (+213.5%) while the worst was 2016 (-75.7%).
For informational and educational purposes only, not investment advice.
